In support of these earlier reports, we found that RAN rs14035 CT heterozygotes and XPO5 rs11077 AA genotype carriers experienced reduced susceptibility to CRC, a link that was especially apparent in male patients. This evidence concerns the gene XPO5 and colorectal carcinoma.